Drug manufacturer Bausch Health last week said on the U.S. Health Resources and Services Administration website that its branded NDCs “will once again be available at the 340B ceiling price” through AmeriSourceBergen Corp. (ABC) “for eligible 340B purchases made by 340B covered entities and 340B contract pharmacies.”
Bausch Health blindsided 340B covered entities on New Year’s Eve, announcing that starting the very next day, Jan. 1, more than 200 of its branded products and future branded products would no longer be available through ABC “for 340B covered entities and 340B contract pharmacies for purchases at the 340B ceiling price.” No explanation for the disruption was ever given.
Drug manufacturer Bausch Health last week said on the U.S. Health Resources and Services Administration website that its branded NDCs “will once again be available at the 340B ceiling price” through AmeriSourceBergen Corp. (ABC) “for eligible 340B purchases made by 340B covered entities and 340B contract pharmacies.”
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
